NC-762

N/A

Report date: 2024/04/03 20:05:50

Base Information

Drug NameNC-762
Drug Alias NameNC-762
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionV-set domain-containing T-cell activation inhibitor 1 inhibitors
TargetsV-set domain-containing T-cell activation inhibitor 1
Therapy Area/IndicationsSolid tumoursCarcinoma, Non-Small-Cell LungOvarian Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNextcure Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNextcure Inc
Active IndicationsN/A
Inactive IndicationsSolid tumoursCarcinoma, Non-Small-Cell LungOvarian Neoplasms +[4] 

Other Information

ATC CodeN/A
Related LinksN/A